" class="no-js "lang="en-US"> Anthos Therapeutics - Medtech Alert
Thursday, March 28, 2024
Anthos Therapeutics | Pharmtech Focus

Anthos Therapeutics

About Anthos Therapeutics

Anthos Therapeutics

Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated innovative therapies to advance care for people living with cardiovascular and metabolic (CVM) diseases.

Anthos Therapeutics aims to combine the agility of a biotech with the rigor of a large pharmaceutical company. Anthos Therapeutics was launched by Blackstone Life Sciences in 2019.

Related Story

Anthos Therapeutics Appoints David McIntyre as Chief Financial Officer

January 6 2022

Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today […]